E. D. Bruin

Cancer Caspase-3 Activity Predicts Local Recurrence in Rectal

H. Putter, C. Marijnen, P. Kuppen, 2019 .

Epithelial Human LeukocyteAntigen-DRExpression Predicts Reduced Recurrence Rates and Prolonged Survival in Rectal Cancer Patients

E. D. Bruin, J. Han-j, M. V. Krieken, 2008 .

COX-2 expression in rectal cancer is of prognostic significance in patients receiving preoperative radiotherapy

H. Putter, C. Marijnen, C. Velde, 2007 .

Abstract P5-21-32: AZD5363 in combination with fulvestrant in AKT1-mutant ER-positive metastatic breast cancer

B. Taylor, S. Chandarlapaty, J. Baselga, 2018 .

Genome-Wide siRNA Screen for Anti-Cancer Drug Resistance in Adherent Cell Lines

J. Downward, M. Howell, M. Jiang, 2015 .

Decreased glutathione biosynthesis contributes to EGFR T 790 M-driven 1 erlotinib resistance in non-small cell lung cancer 2

E. Smit, J. Downward, O. Pardo, 2016 .

BEECH: a dose-finding run-in followed by a randomised phase II study assessing the efficacy of AKT inhibitor capivasertib (AZD5363) combined with paclitaxel in patients with estrogen receptor-positive advanced or metastatic breast cancer, and in a PIK3CA mutant sub-population

K. Tamura, C. Corcoran, G. Schiavon, 2019, Annals of oncology : official journal of the European Society for Medical Oncology.

University of Birmingham Tracking genomic cancer evolution for precision medicine : the lung TRACERx study

Nicolai J. Birkbak, R. Booton, H. Davies, 2014 .

Automated segmentation of murine lung tumors in x-ray micro-CT images

Luis Pizarro, Joshua K. Y. Swee, Julian Downward, 2014, Medical Imaging.